The final Over-Myr consortium meeting was organized on 10-11 June 2015 in Vienna, Austria
Over-Myr was present at the European Hematology Association with a satellite symposium on 12 June 2015 in Vienna, Austria.
The presentation was given by Dirk Hose.
Over-Myr Consortium Meeting took place in Eisenach, Germany on the 5th of June 2014
Karin Vanderkerken (Scientific Coordinator) Surinder Sahota (Partner from the University of Southampton)
Oncodesign integrates OVER-MyR
Oncodesign integrated the OVER MyR network in January 2013 and is now full member of the project. The company will be responsible for the selection of highly potent and selective kinase inhibitors able to overcome MM drug resistance. "This program fits perfectly in our R&D internal initiative focused on Resistance to Targeted Therapies" said Jan Hoflack, CSO of Oncodesign. More info on ONCODESIGN